Last reviewed: June 28, 2026
Last updated: June 28, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Zepbound and similar GLP-1 receptor agonists work by slowing how quickly your stomach empties food into your intestines—a mechanism that drives weight loss but can also trigger constipation as a side effect. Clinical trials show approximately one in four patients on GLP-1 therapy experience some degree of bowel regularity changes. Understanding evidence-based management strategies helps you stay comfortable while reaching your health goals.
How GLP-1 Medications Affect Bowel Function
GLP-1 receptor agonists activate specific brain and gut receptors that regulate appetite and digestion speed. When your stomach empties more slowly, your intestines have more time to absorb water from stool, making bowel movements harder and less frequent. This is a direct pharmacological effect, not a sign that your body is rejecting the medication.
The intensity of constipation varies by individual and depends partly on your genetic makeup. PlexusDx Precision Peptide Genetic Test identifies variants in genes like MC4R and FTO that influence how your digestive system responds to peptide-based therapies, allowing for more targeted management strategies tailored to your biology.
Most constipation related to GLP-1 use is mild to moderate and manageable with non-medication approaches. Severe or persistent constipation warrants contact with your healthcare provider to rule out other causes and discuss medication adjustments.
Hydration and Fiber Strategies for GLP-1 Constipation Relief
Water intake is your first line of defense against constipation on GLP-1 therapy. Aim for at least 2.5 to 3 liters daily, spreading fluid intake evenly throughout the day rather than consuming large amounts at once. Proper hydration softens stool and supports the osmotic movement needed for regular bowel function.
Soluble fiber sources—such as oatmeal, flaxseeds, chia seeds, and psyllium husk—draw water into your intestines and promote gentler, more frequent bowel movements. Start with 5 to 10 grams of additional fiber daily and increase gradually over one to two weeks to avoid bloating. Insoluble fiber from whole grains and leafy vegetables adds bulk but works best when paired with adequate fluid intake.
Many patients find success by eating smaller, more frequent meals rather than three large ones. This reduces the volume of food your already-slowed stomach must process, decreasing discomfort and bloating while supporting regular bowel transit.
Over-the-Counter Options and When to Use Them
Stool softeners like docusate sodium (Colace) are often the gentlest first choice, working by allowing water to mix with stool for easier passage. These are typically safe for long-term use and carry minimal side effects. Unlike stimulant laxatives, stool softeners do not force bowel contractions and are considered safer for daily management of GLP-1-related constipation.
Osmotic laxatives such as polyethylene glycol (MiraLAX) or magnesium citrate pull water into the intestines, encouraging bowel movements without chemical stimulation. These work well for occasional use but should not be your sole strategy. Stimulant laxatives like senna should be reserved for infrequent use only, as regular dependence can reduce your colon's natural responsiveness.
Probiotics containing lactobacillus or bifidobacterium species may support digestive comfort, though clinical evidence for constipation relief remains modest. If you choose a probiotic, select one with at least 10 billion CFU and continue for at least two weeks to allow beneficial bacteria time to establish.
Lifestyle and Dietary Adjustments to Support Bowel Health
Physical activity stimulates intestinal muscles and accelerates stool movement through your colon. Even light exercise—30 minutes of walking daily—can meaningfully reduce constipation severity in patients on GLP-1 therapy. Movement also reduces bloating and improves overall digestive comfort.
Eating warm foods and beverages, particularly warm liquids like herbal tea or warm lemon water, can support natural bowel reflexes. Many people find that drinking a warm beverage upon waking triggers their body's gastrocolic reflex, promoting regular morning bowel movements. Timing meals consistently each day also helps train your digestive system.
If you're taking Tirzepatide Injection through PlexusDx or another GLP-1 compound, discuss constipation management with your provider at your regular check-ins. Some patients benefit from temporary dose adjustments or timing changes as their digestive system adapts over weeks two through eight of therapy.
Personalized Management With PlexusDx Precision Testing
Individual responses to GLP-1 therapy—including constipation risk—are shaped by your peptide-pathway genetics. PlexusDx Precision Peptide Genetic Test examines 14 metabolic and digestive pathways across 49 peptides, including genetic variants in GLP1R, GIPR, and MC4R that predict how your digestive system will respond to medication.
Patients who understand their genetic profile can work with their healthcare provider to anticipate constipation risk and implement preventive strategies from day one. This personalized approach often results in faster comfort and better medication adherence. The test costs $99 as an add-on after your first month of treatment with PlexusDx, making genetic insights accessible and actionable.
PlexusDx compounds Tirzepatide Injection starting at $249 per month through licensed 503A pharmacies, with no insurance required and HSA/FSA eligibility. When paired with personalized genetic data, this investment supports both effective weight loss and comfortable, side-effect-free therapy.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is constipation on Zepbound permanent?
No. Constipation from GLP-1 therapy is typically temporary and improves as your body adapts over four to twelve weeks. Most patients maintain symptom relief through hydration, fiber, and activity without needing ongoing medication. Contact your provider if constipation persists beyond eight weeks.
Can I stop taking Zepbound to relieve constipation?
Stopping medication is not recommended without guidance from your healthcare provider. Constipation is manageable through the strategies outlined above, and discontinuing therapy loses your weight loss progress. Discuss constipation concerns with your doctor to find solutions that work for both your digestive comfort and your health goals.
Does PlexusDx Tirzepatide Injection cause less constipation than Zepbound?
Constipation risk depends on the active ingredient (semaglutide or tirzepatide) and dose, not the brand or manufacturer. PlexusDx compounds both medications through licensed 503A pharmacies. Individual responses vary; the PlexusDx Precision Peptide Genetic Test helps predict your personal risk and guide preventive strategies.
What if diet and fiber don't relieve my constipation?
If constipation persists after two weeks of hydration, fiber, and activity increases, contact your healthcare provider. They may recommend an osmotic laxative, adjust your GLP-1 dose timing, or explore whether other medications you take might be contributing. Never assume constipation is unavoidable on GLP-1 therapy.
Can the Precision Peptide Genetic Test predict my constipation risk?
Yes. PlexusDx Precision Peptide Genetic Test examines 150+ genetic insights across digestive and metabolic pathways, including MC4R variants linked to satiety signaling and bowel transit. Understanding your genetic profile allows proactive constipation management before symptoms develop. The test is $99 and available after one month of treatment with PlexusDx.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Optimizing Your Journey: What I Eat in a Day on Ozempic for Sustained Wellness
Can Type 1 Diabetics Take Zepbound for Weight Loss?